The effect of transforming growth factor β1 gene polymorphisms in ankylosing spondylitis

Rheumatology

Volumn 43, Issue 1, 2004, Pages 32-38

  Jaakkola, E ^e   Crane, A M ^e   Laiho, K ^b   Herzberg, I ^e   Sims, A M ^e   Bradbury, L ^e   Calin, A ^a   Brophy, S ^a   Kauppi, M ^b   Kaarela, K ^b   Wordsworth, B P ^e   Tuomilehto, J ^c,d   Brown, M A ^e,f  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f Spondyloarthritis/Bone Dis Res Grp   (United Kingdom)

Author keywords

Cytokines; Genetic aetiology; Microsatellites; Polygenic; Spondyloarthropathy

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CENTROMERE; CHROMOSOME 19; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FAMILY STUDY; FEMALE; FINLAND; FUNCTIONAL ASSESSMENT; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC PARAMETERS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; ONSET AGE; PARENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT; QUESTIONNAIRE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; UNITED KINGDOM;

ADULT; CHI-SQUARE DISTRIBUTION; ENGLAND; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-B27 ANTIGEN; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING; TRANSFORMING GROWTH FACTOR BETA;

EID: 9144250214     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg457     Document Type: Article

References (59)

1. Hamersma J, Cardon LR, Bradbury L et al. Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum 2001;44:1396-400.
2. Brown MA, Kennedy LG, MacGregor AJ et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
3. Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000;59:883-6.
4. Kennedy LG, Will R, Calin A. Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. J Rheumatol 1993;20:1900-4.
5. Hoyle E, Laval SH, Calin A, Wordsworth BP, Brown MA. The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum 2000;43:1353-5.
6. Laval SH, Timms A, Edwards S et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
7. Reveille JD. Progress in whole genome scans: the North American experience. Clin Exp Rheumatol 2002;20:590.
8. Rioux JD, Silverberg MS, Daly MJ et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863-70.
9. Archer JR. Ankylosing spondylitis, IgA, and transforming growth factors. Ann Rheum Dis 1995;54:544-6.
10. Noda M, Camilliere JJ. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 1989;124: 2991-4.
11. Laurent MR, Panayi GS. Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 1983;42:524-8.
12. MacLean IL, Archer JR, Cawley MI et al. Immune complexes in ankylosing spondylitis. Ann Rheum Dis 1992;51:83-6.
13. Maki-Ikola O, Lehtinen K, Granfors K. Similarly increased serum IgA1 and IgA2 subclass antibody levels against Klebsiella pneumoniae bacteria in ankylosing spondylitis patients with/without extra-articular features. Br J Rheumatol 1996;35:125-8.
14. Baeten D, Van Damme N, Van den Bosch F et al. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha. Ann Rheum Dis 2001;60:750-5.
15. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
16. Czarniecki CW, Chiu HH, Wong GH, McCabe SM, Palladino MA. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol 1988;140:4217-23.
17. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000;14:23-42.
18. Chen W, Wahl SM. Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect 1999;1:1367-80.
19. Crane AM, Bradbury L, van Heel DA et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum 2002;46:1629-33.
20. Goedecke V, Crane AM, Jaakkola E et al. Interleukin 10 polymorphisms in ankylosing spondylitis. Genes Immun 2003;4:74-6.
21. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
22. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
23. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
24. Lympany PA, Avila JJ, Mullighan C, Marshall S, Welsh KI, du Bois RM. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 1998;52:573-8.
25. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
26. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999;65: 1170-7.
27. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997;61:1179-88.
28. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
29. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000;66:279-92.
30. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
31. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120:849-52.
32. Abecasis GR, Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-3.
33. Chen WM, Deng HW. A general and accurate approach for computing the statistical power of the transmission disequilibrium test for complex disease genes. Genet Epidemiol 2001;21:53-67.
34. Syrris P, Carter ND, Metcalfe JC et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998;95:659-67.
35. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-20.
36. Tiret L, Poirier O, Nicaud V et al. Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases. Hum Mol Genet 2002;11:419-29.
37. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994;37:23-31.
38. Sugiura Y, Niimi T, Sato S et al. Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 2002;61:826-8.
39. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis 2002;61:678-81.
40. Yamada Y, Miyauchi A, Goto J et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569-76.
41. Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997;20:289-94.
42. Kamiya M, Harada A, Mizuno M, Iwata H, Yamada Y. Association between a polymorphism of the transforming growth factor-beta1 gene and genetic susceptibility to ossification of the posterior longitudinal ligament in Japanese patients. Spine 2001;26:1264-6; discussion 1266-7.
43. Yamada Y, Okuizumi H, Miyauchi A, Takagi Y, Ikeda K, Harada A. Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 2000;43:452-60.
44. Garcia-Gonzalez MA, Crusius JB, Strunk MH et al. TGFB1 gene polymorphisms and inflammatory bowel disease. Immunogenetics 2000;51:869-72.
45. Schulte CM, Goebell H, Roher HD, Schulte KM. C-509T polymorphism in the TGFB1 gene promoter: impact on Crohn's disease susceptibility and clinical course? Immunogenetics 2001;53:178-82.
46. McGarry F, Cousins L, Sturrock RD, Field M. A polymorphism. within the transforming growth factor β1 (TGFβ1) gene is associated with ankylosing spondylitis (AS). Rheumatology 2001;41(Suppl 1):16.
47. Varilo T, Paunio T, Parker A et al. The interval of linkage disequilibrium (LD) detected with microsatellite and SNP markers in chromosomes of Finnish populations with different histories. Hum Mol Genet 2003;12:51-9.
48. Eaves IA, Merriman TR, Barber RA et al. The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet 2000;25:320-3.
49. Taillon-Miller P, Bauer-Sardina I, Saccone NL et al. Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet 2000;25:324-8.
50. Cambien F, Ricard S, Troesch A et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996;28:881-7.
51. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
52. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411: 603-6.
53. Rioux JD, Daly MJ, Silverberg MS et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-8.
54. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R. New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet 1989;2:299-302.
55. Jawaheer D, Li W, Graham RR et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002;71:585-94.
56. Zippert R, Bassler A, Holmer SR, Hengstenberg C, Schunkert H. Eleven single nucleotide polymorphisms and one triple nucleotide insertion of the human TGF-beta III receptor gene. J Hum Genet 2000;45:250-3.
57. Braun J, Bollow M, Neure L et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
58. Murray PI, Clay CD, Mappin C, Salmon M. Molecular analysis of resolving immune responses in uveitis. Clin Exp Immunol 1999;117:455-61.
59. Grainger DJ, Heathcote K, Chiano M et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8:93-7.